Shares of Divi’s Laboratories zoomed 5% on BSE in Monday’s trade to hit its fresh 52-week high of Rs 4,335 as brokerages like Motilal Oswal and InCred are bullish on the stock after the company posted a 68% year-on-year (YoY) increase in its Q4 profits at Rs 538 crore. The consolidated revenue in the reported … Read more
Retailer and hypermarket operator Trent and state-owned Bharat Electronics are likely to replace LTI Mindtree and Divi’s Laboratories in the forthcoming rejig in the Nifty index, according to an estimate by Nuvama Alternative & Quantitative Research. The possible changes would lead to an inflow of $429 million or Rs 3,500 crore into Trent and $ … Read more
Brokerage firm Macquarie maintained a neutral rating on Bandhan Bank, Divi’s Laboratories recommended a sell rating on Divi’s Laboratories, BofA Securities recommended a buy on Biocon, and JPMorgan upgraded LIC to overweight. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Macquarie on Bandhan Bank: Neutral| Target Rs … Read more
Divi’s Laboratories Ltd, part of the pharma industry, gave a breakout from an inverse Head & Shoulder pattern on daily charts to hit a fresh 52-week high last week which suggests that the trend is in favour of bulls. Short-term traders can look to buy the stock for a possible target above 4000-4300 levels in … Read more
